Dr. Rath Research Institute

Flu season is here. However, a new study finds that flu shots aren't as effective as previously thought.

Comments: With flu season beginning, the controversy over the flu vaccine continues to rise. It is about time that researchers and physicians agree that the flu vaccine does not work as well as expected. It carries many more risks than benefits. The Lancet published a study after meta-analysis of 31 clinical trials published since 1998. This analysis concluded that the flu vaccine might protect only 59% of the healthy adults and not 80-90% of healthy adults as previously projected. Moreover, this study once again highlighted the fact that there is no satisfactory evidence of protection from influenza for people 65 years or older although this is the group that most need it. People over 70 account for two-thirds of all flu deaths. Although doubts over the efficacy of the flu vaccine continues to rise every year, it is still recommended for everyone ages 6 months and above.

Flu vaccines are typically designed to protect against three strains of influenza virus (Trivalent vaccine). The flu virus mutates rapidly and quickly develops resistance to available treatments and even vaccines. Therefore, the vaccine must be modified and administered every year. Immunological experts estimate which strains of influenza should be included in the next season’s batch, based on the prior flu season. Obviously, it is very difficult to predict the exact vaccine composition that would be effective. In addition to the allergic reactions, many other sometimes serious adversities are known to occur over long-term exposure to vaccine additives.

The influenza vaccine was never put through stringent placebo-controlled trials, which are considered the gold standard in the industry. Most of the studies conducted on flu vaccines are observational. In those studies, scientists draw conclusions about the effect of a treatment on a population by comparing what happens to a group that has the treatment with what happens to a similar group that does not. In the current guidelines to annually vaccinate, almost all are based on very limited evidence of safety and efficacy. It is interesting to note that despite overwhelming evidence questioning the efficacy and some studies clearly proving otherwise, the Center for Disease Control is not willing to change its recommendations about the flu vaccination. In 2010, the global market for seasonal influenza vaccines was estimated to have reached $3.8 Billion.

Conventional methods have failed to give any satisfactory options for people to fight the yearly influenza attacks. On the other hand, Dr. Rath's scientific team has established significant efficacy of natural
 nutrients such as vitamin C, amino acids lysine and proline, with other synergistic nutrients in combating the influenza virus. In the influenza research, Dr. Rath’s scientific team discovered that viruses 
spread by the degradation of collagen, and that such degradation can be prevented with the use of the essential amino acid lysine along with vitamin C and proline. These nutrients work in synergy to
 create the best defense against influenza. It is distressing to see that although there are safe and effective alternative approaches to fight viral infections; ineffective vaccines continue to be pushed by 
healthcare providers and governmental agencies. Please more about the research and publications from Dr. Rath's Research Institute using nutrient synergy to combat influenza viruses at:
 www.drrathresearch.org

Source: http://www.kxly.com/news/29599245/detail.html